tgtx seeking alpha：TGTX TG Therapeutics
TGTX TG Therapeutics
7天前—TGTherapeutics,Inc.(TGTX)growthgradeandunderlyingmetrics.QuantRatings,revenuegrowth,EBITDA,EPS,cashflow,ROE,compounded, ...。其他文章還包含有：「TGTherapeuticsspikesasCEObuys$1Mshares」、「TGTherapeutics」、「TGTherapeutics」、「TGTherapeutics」、「TGTherapeutics」、「TGTherapeutics」、「TGTXTGTherapeutics」、「TGTXTGTherapeutics」、「TGTXTGTherapeutics」
查看更多 離開網站
TG Therapeutics spikes as CEO buys $1M shares
https://seekingalpha.com
TG Therapeutics (TGTX) traded sharply higher on Monday after the biotech's chief executive, Michael Weiss, bought more than $1M worth of ...
TG Therapeutics
https://seekingalpha.com
TGTX TG Therapeutics, Inc. Latest News. Follow 16.5K followers. $10.75-0.78 (-6.76%)4:00 PM 08/16/23. NASDAQ | $USD | Market Close.
TG Therapeutics
https://seekingalpha.com
TG Therapeutics, Inc.'s stock symbol is TGTX and currently trades under NASDAQ. It's current price per share is approximately $10.53. What are your TG ...
TG Therapeutics
https://seekingalpha.com
TG Therapeutics, Inc. (TGTX) Valuation Grade and underlying metrics. Quant Ratings. PE ratios, EBITDA, EPS, cash flow, ROE. Compounded.
TG Therapeutics
https://seekingalpha.com
Stock Evaluation. Looking at Seeking Alpha data: TG Therapeutics presents a mixed investment picture. On the positive side, the company's EPS ...
TG Therapeutics
https://seekingalpha.com
Shares of TG Therapeutics plunged after a Q2 revenue miss and the Neuraxpharm deal for ex-U.S. rights of Briumvi.
TGTX TG Therapeutics
https://seekingalpha.com
TG Therapeutics, Inc. (TGTX) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts.
TGTX TG Therapeutics
https://seekingalpha.com
Stock market Insights & financial analysis, including free earnings call transcripts, investment ideas and ETF & stock research written by finance experts.
TGTX TG Therapeutics
https://seekingalpha.com
Find the latest TG Therapeutics, Inc. (TGTX) stock analysis from Seeking Alpha's top analysts: exclusive research and insights from bulls and bears.